Lv3
340 积分 2023-02-20 加入
Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort
2天前
已完结
The first Chinese National Union of Real-world Gynaecological Oncology Research and Patient Management Platform: A retrospective study
23天前
已完结
A vaccine to treat ALK+ lung cancer and prevent metastatic disease
1个月前
已完结
Poly(ADP-ribose) polymerase inhibition: past, present and future
1个月前
已完结
New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection
1个月前
已完结
Handbook of Advanced Cancer Care
2个月前
已完结
Handbook of Advanced Cancer Care
2个月前
已关闭
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial
3个月前
已完结
Advances in Development of Selective Antitumor Inhibitors That Target PARP-1
4个月前
已完结
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics
4个月前
已完结
皖公网安备34019202002308
